Renauld-Mongenie; Genevieve

Patent Applications and Registrations

Patent applications and USPTO patent grants for Renauld-Mongenie; Genevieve.The latest application filed is for "meningococcal vaccine based on lipooligosaccharide (los) originating from modified neisseria meningitidis strains of immunotype l6".

Company Profile

2.10.12

Renauld-Mongenie; Genevieve - Chaponost FR
Renauld-Mongenie; Genevieve - Lyons FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 App 20190117684 - Mistretta; Noelle ; et al.	2019-04-25
Compositions comprising N. meningitidis proteins Grant 10,232,029 - Renauld-Mongenie , et al.	2019-03-19
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Grant 10,137,145 - Mistretta , et al. November 27, 2	2018-11-27
Neisseria Meningitidis Trypsin-like Serine Protease Polypeptides And Compositions Thereof App 20180125961 - ARNAUD-BARBE; Nadege ; et al.	2018-05-10
Meningitidis Vaccines Comprising Subtilinases App 20180125960 - ARNAUD-BARBE; Nadege ; et al.	2018-05-10
Compositions Comprising N. Meningitidis Proteins App 20180125959 - RENAULD-MONGENIE; Genevieve ; et al.	2018-05-10
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 App 20180036339 - Mistretta; Noelle ; et al.	2018-02-08
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Grant 9,669,052 - Mistretta , et al. June 6, 2	2017-06-06
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 App 20160045535 - Mistretta; Noelle ; et al.	2016-02-18
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 Grant 9,132,181 - Mistretta , et al. September 15, 2	2015-09-15
Nucleic acids and polypeptides specific of the Neisseria genus pathogenic strains Grant 8,309,100 - Aujame , et al. November 13, 2	2012-11-13
Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis Protein App 20120156281 - Haensler; Jean ; et al.	2012-06-21
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 App 20100330160 - Mistretta; Noelle ; et al.	2010-12-30
Nucleic Acids And Polypeptides Specific Of The Neisseria Genus Pathogenic Strains App 20100184639 - AUJAME; Luc ; et al.	2010-07-22
Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus Grant 7,704,513 - Aujame , et al. April 27, 2	2010-04-27
Nucleic Acids And Polypeptides Specific For Pathogenic Strains Of The Neisseria Genus App 20090155886 - AUJAME; Luc ; et al.	2009-06-18
Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus Grant 7,384,768 - Aujame , et al. June 10, 2	2008-06-10
Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus App 20050032103 - Aujame, Luc ; et al.	2005-02-10
Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains Grant 6,835,384 - Aujame , et al. December 28, 2	2004-12-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.